Catalytic funding of viral hepatitis elimination program in Uzbekistan
Rick Dunn, Homie Razavi(Center for Disease Analysis), Shokhista Bakieva(Center for Disease Analysis), Shakhlo Sadirova(Tashkent Chemical-Technological Institute), Kathryn Razavi‐Shearer(Center for Disease Analysis), Erkin Musabaev(Hai phong University Of Medicine and Pharmacy)
Cited by 0
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484